Kimberly Nelson, PA
Physician Assistant · Sioux Falls, SDNPI 1831478221
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,400 of the $10,689 with a category attached, or 78.6%. AstraZeneca accounts for 92.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $4,714 and has fallen 86.1% since, to $654 in 2025. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 48 payments — averaging $222.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$10K
- Adaptive Biotechnologies Corporation$151
- Pharmaessentia USA Corporation$122
- Johnson & Johnson$111
- Gilead$97
- AbbVie$86
- plus $257 from 8 others
What the payments were for
- Speaking & faculty fees$8,40079%
- Travel & lodging$6146%
- Food & beverage$1,67516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 28 | $9,865 |
| Adaptive Biotechnologies Corporation | 2 | $151 |
| Pharmaessentia USA Corporation | 3 | $122 |
| Johnson & Johnson(2 entities) | 2 | $111 |
| Gilead | 1 | $97 |
| AbbVie | 2 | $86 |
| E.r. Squibb & Sons, L.L.C. | 1 | $57 |
| Genentech USA, Inc. | 2 | $38 |
| Beigene USA, Inc. | 2 | $37 |
| Bristol Myers Squibb | 1 | $34 |
| Karyopharm Therapeutics Inc. | 1 | $31 |
| Novartis | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CALQUENCE$9,223
How this compares
$10,689 in reported general payments places this provider in the 95th percentile of 548 physician assistant providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CalquenceAcalabrutinib Maleate | 32 | $441,768 |
| RevlimidLenalidomide | 26 | $426,175 |
| BrukinsaZanubrutinib | 23 | $336,388 |
| JakafiRuxolitinib Phosphate | 11 | $167,678 |
| SprycelDasatinib | 14 | $159,102 |
| PromactaEltrombopag Olamine | 12 | $83,012 |
| XareltoRivaroxaban | 13 | $7,558 |
| Atovaquone | 14 | $5,600 |
| Hydroxyurea | 51 | $966 |
| Acyclovir | 70 | $927 |
| Dexamethasone | 29 | $341 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 25 | $92 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaCalquence | $9,865 | $441,76832 claims |
| Bristol Myers SquibbRevlimid | $34 | $426,17526 claims |
| Beigene USA, Inc.Brukinsa | $37 | $336,38823 claims |
| E.r. Squibb & Sons, L.L.C.Sprycel | $57 | $159,10214 claims |
| NovartisPromacta | $22 | $83,01212 claims |
| Johnson & JohnsonXarelto | $111 | $7,55813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Sioux Falls
- Christina PekoskeSioux Falls$9K
- Rachel HotvetSioux Falls$8K
- Gabriel PenaredondoSioux Falls$7K
- Virginia LemmeSioux Falls$6K
- Kathrine JibbenSioux Falls$6K
- Austen FagerlandSioux Falls$6K
- Cheryle BrandtSioux Falls$6K
- Rachelle BroveleitSioux Falls$5K
- Stephanie SteltonSioux Falls$5K
- Joseph NewmanSioux Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.